Tailoring dosages to a patient’s DNA cuts side effects by a third, ‘groundbreaking’ study finds

Patients given medication tailored specifically for their DNA experienced 30 per cent fewer side effects, a “groundbreaking” study has found. The findings were the result of the work of an international team led by researchers at Leiden University Medical Center (LUMC), which set out to demonstrate how prescribing drugs based on a person’s genetic information could have reap benefits. The problem with how drugs are prescribed currently in most settings, the researchers argue, is that it is a one-size-fits-all approach. In reality, everybody is different, and may need a different dosage of a dr…